Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Prope... (us Biotechnologies Corporation is a priv...)

HOME >> BIOLOGY >> TECHNOLOGY

Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate

Date:12/16/2008

us Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its proprietary targeted delivery systems. To learn more about our pipeline of proprietary biotechnologies currently available for clinical development and/or new product development, please visit us at http://www.epeiusbiotech.com.

For more information about Rexin-G(R), on-going clinical trials in the USA and abroad, and/or Epeius pathotropic (disease-seeking) gene delivery systems, please contact Erlinda M. Gordon, M.D., at egordon@epeiusbiotech.com.

*(LOGO 72dpi: Send2press.com/mediaboom/08-0421-Epeius_72dpi.jpg)

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Targeting Metastatic Cancer From the Inside: Epeius Biotech Reveals a New Generation of Tools for Medical Gene Delivery
2. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
3. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
4. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
5. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
8. Oncolytics Biotech Inc.s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study
9. Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc.
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Investor Group Reconfigures Proposed Slate of Replacement Directors for Trinity Biotech

Post Your Comments:

(Date:11/24/2009)...wire-FirstCall/--ArenaPharmaceuticals,Inc.(Nasdaq:...presentatthePiperJaffray21stAnnualHealthCareConfer....PacificTime)attheNewYorkPalaceHotelinNewYorkCity....r,isscheduledtoprovideanoverviewofthecompany,inclu..., Aliveaudiowebcastofthepresentationwillbeavaila...

(Date:11/24/2009)...irstCall/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA...frayHealthCareConference.TheconferencewillbeheldDe...illpresentonTuesday,December1at11:00a.m.EasternTim...ntationwillbeavailableat www.celltherapeutics.com ...PiperJaffrayHealthCareConference,NewYorkPalaceHote...

(Date:11/23/2009)...PRNewswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasd...vember27,2009astheex-dividenddateforits$200million...itizationtransactioncompletedonNovember2,2009.Thed...sofrecordontherecorddate,December1,2009.NASDAQhass...pershareofcommonstockforpurposesoftheex-dividendda...

(Date:11/23/2009)...e/-InimexPharmaceuticals,Inc.announcedtodaythatith...O. ,, Abramsbringsmorethan25yearsofdrugdiscover...ofthenuclearmedicineimagingagent,Cardiolite,andwor...ager,BiomedicalResearchWorldwide.In1996,Abramsledt...tandCEOfrom1996to2006.AnorMEDdiscoveredanddevelope...

Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2 PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2 Inimex Announces Appointment of New CEO 2

[0] Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference [0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference [0] PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend [0] Inimex Announces Appointment of New CEO

...OLIS, Md., May 8 PharmAthene, Inc. (NYSE Amex: ...termeasures against biological and chemical threat...009 financial results. The Company,s first quarter...iday, May 15, 2009. , , PharmAthene management wi...st quarter 2009 financial results. The call is sc...

...LE, May 8 Dendreon Corporation (Nasdaq: DNDN ) ...lic offering of 10,700,000 shares of its common st...nager for the offering. Dendreon has granted Deut...ditional 1,279,166 shares of common stock to cover...to use the net proceeds of the offering to develop...

...OUIS, May 7 Lee Biosolutions has announced that i...e to include recombinant C-Reactive Protein. , ,...d that operates as a marker for inflammation, mean...nflammation in the body. Inflammation is a normal ...injury, fever and infection. Inflammation is also ...

Other Biology Technology:Dendreon Announces Common Stock Offering 2

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast Dendreon Announces Common Stock Offering Recombinant C-Reactive Protein

(Date:11/24/2009)...GE Antarctica has long held secrets of the earth,...ntly, there has been very little information on th... of ice for millions of years. Now, a team of rese...e been funded to the tune of $10 million dollars b...to the bottom of things literally. These scientis...

(Date:11/23/2009)...ew research presents strong evidence that the "syn...tdoor traffic-related pollution and indoor endotox...r the other exposure alone. , Environmental he...C) College of Medicine have shown that children ex...cles and indoor endotoxin during early life are si...

(Date:11/23/2009)...dy by the Wildlife Conservation Society says that ...n the Republic of Congopart of the "mother lode" o...re becoming increasingly threatened by growing hum...ds protection of the swamp forests adjacent to the...r recent surveys confirmed that high densities of ...

[0] LSU gets to the bottom of things -- in Antarctica [0] Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later [0] A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable

... regulate mosquitoes growth have been identified a...ant state to survive winters cold. , The researc...to life cycle and appears to shed some light on ho...he winter months. , The shorter days of autumn tr... a hibernation-like state of arrested development ...

... hole could modify climate change in the Southern ...ording to scientists from the University of Colora...c Administration and NASA. , While Earth,s averag...nterior of Antarctica has exhibited a unique cooli... by ozone depletion, said Judith Perlwitz of the C...

...gy they designed, Duke University bioengineers can...e skull to see in real-time the arteries within th... , The researchers believe that these advances wi...ents, whether by giving emergency medical technici... potential stroke victims while in the ambulance o...

Other Biology News:Pathway found that lets mosquitoes fatten up, slow down for winter 2 Pathway found that lets mosquitoes fatten up, slow down for winter 3 Ozone hole recovery may reshape southern hemisphere climate change 2 Ozone hole recovery may reshape southern hemisphere climate change 3 New 3-D ultrasound could improve stroke diagnosis, care 2 New 3-D ultrasound could improve stroke diagnosis, care 3

Pathway found that lets mosquitoes fatten up, slow down for winter Ozone hole recovery may reshape southern hemisphere climate change New 3-D ultrasound could improve stroke diagnosis, care

Rabbit Anti-MKK6, phospho (Ser207) Polyclonal Antibody, Unconjugated from Abcam

Custom Oligo Assay Single Locus 1920 samples from Illumina

Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam

Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents

Biology Products:

Rabbit Anti-MKK6, phospho (Ser207) Polyclonal Antibody, Unconjugated from Abcam Custom Oligo Assay Single Locus 1920 samples from Illumina Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents

Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Prope...(us Biotechnologies Corporation is a priv...)